Introduction {#s1}
============

While many interventions that delay age-associated declines have been described in laboratory studies, instances of pausing or even reversing aging are relatively rare and generally do not preserve or restore youthful function in all tissues of an animal ([@bib24]). Diapause states have been discovered in *C. elegans* that apparently preserve or restore functionality of chronologically old tissues after diapause exit. One example of such a state is the adult reproductive diapause (ARD), which is induced in developmentally mature animals by starvation. The animals show signs of tissue and cellular aging over a period of several weeks, but become apparently fully rejuvenated and proceed to have a normal adult lifespan after exit from ARD ([@bib4]).

Depending on the developmental point at which *C. elegans* face starvation, animals can enter diapause at either the first larval stage L1 (L1 arrest), the second larval stage L2 (dauer), or, in the case of ARD, just after the transition from the fourth larval stage (L4) to young adulthood ([@bib4]; [@bib22]; [@bib28]). Developmental arrests at the third and fourth larval stages (L3 and L4) have also been recently described, but are less studied ([@bib36]). Dauer is the most studied diapause in worms and represents a clearly distinct, alternative third larval stage that is highly stress resistant and long-lived ([@bib28]; [@bib51]; [@bib12]). Dauer worms undergo significant anatomical transformations, such as synthesis of the specialized cuticle and mouth plug ([@bib13]; [@bib21]). These morphological changes make it difficult to investigate aging at the cellular and molecular level in dauer animals, although animals that have exited dauer after a prolonged period of time have a normal adult lifespan ([@bib12]).

Unlike dauer, ARD does not require major anatomical transformations and therefore may provide direct insight into the mechanisms that preserve functionality of cells and tissues during prolonged diapause and restore them upon the diapause exit. Entry into ARD occurs when animals face starvation at the transition from the L4 stage of development to adulthood ([@bib4]). During ARD, developmentally mature animals show signs of tissue and cellular aging along with reduction of the germline, atrophy of intestine and somatic gonad, and appearance of dead embryos in the uterus ([@bib4]). Careful analysis by the Kimble group suggested that the germline is sacrificed for production of a small number of progeny during ARD ([@bib38]). Exit from ARD is marked by drastic morphological improvements: animals resume growth, germline stem cells (GSCs) repopulate the germline, and the atrophied intestine and gonad regain their youthful appearance ([@bib4]). Post-ARD animals appear to be fully rejuvenated. In addition, animals exiting from ARD have a normal adult lifespan and are capable of progeny production despite their time as diapaused adults. Intriguingly, the observed morphological restoration takes place in fully developed adult animals in which all somatic cells are post-mitotic. Although ARD was discovered nearly a decade ago, the signals and molecular mediators of ARD maintenance and exit remain unknown.

In this study, we examined molecular and physiological mechanisms for post-ARD tissue restoration. We found that the DNA synthesis inhibitor 5-fluoro-2\'-deoxyuridine (FUDR) prevents normal recovery from ARD. Surprisingly, neither germline nor somatic DNA synthesis were required for post-ARD tissue recovery. Instead, recovery of somatic tissues involves nucleolar reactivation and a large expansion of the RNA pool, both of which are sensitive to FUDR. These findings provide insight into a key early steps in post-ARD somatic restoration, and allow better understanding of the pleiotropic effects of FUDR, including effects on longevity, that have been observed by many laboratories in recent years ([@bib48]; [@bib1]; [@bib15]; [@bib26]; [@bib2]; [@bib3]).

Results {#s2}
=======

FUDR prevents tissue restoration upon exit from ARD {#s2-1}
---------------------------------------------------

Transition into and exit from the ARD induce dramatic morphological changes. Specifically, entry into the diapause state is marked by cessation of growth, shrinkage of the intestine and somatic gonad, and reduction of the germline ([Figure 1A,B,D](#fig1){ref-type="fig"}). Upon exit from ARD growth resumes, the germline repopulates, and the intestine and gonad regain normal appearance ([Figure 1A,B,D](#fig1){ref-type="fig"}). Importantly, in addition to visual improvements, animals regain youthful levels of functional health measures, such as motility and pharynx pumping (food grinding) ([Figure 1E,F](#fig1){ref-type="fig"}). Therefore, exit from ARD induces functional and morphological restoration to a youthful state. We will use the term 'post-ARD' hereafter to refer to the animals exiting from the diapause. In contrast, genetically matched animals that were never starved are referred to as 'control'.

![FUDR prevents post-ARD recovery.\
(**A**) Representative DIC images of control, ARD and post-ARD animals. Upper panel: control L4 larva, 4 day old control adult, and 4 day old adult treated with FUDR from L4; lower panel: animal after 3 weeks in ARD (ARD), and animals which were allowed to recover from ARD for 4 days with and without FUDR (post-ARD). Insets show dead embryos and non-recovered germline in post-ARD FUDR condition. Scale bar is 100 µm. (**B**) DAPI staining of germline in L4 larva, 4 day old adult (control), animal that spent 3 weeks in diapause (ARD), and animal after 4 days of recovery (post-ARD). Reduced pool of GSCs in ARD animal is indicated by an arrow. Scale bar is 25 µm. (**C**) Survival curves of the control and post-ARD animals with or without FUDR. On day 0 of the experiment, ARD animals after 3 weeks in diapause and control L4 were transferred onto fresh OP50-seeded plates. The next day was considered day1 of adulthood for both conditions. See [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. (**D**) Body length (in micrometers) of L4 larvae, ARD, 4 day old control and post-ARD animals after 4 days of recovery. Shown are mean values ± SEM. See [Figure 1---source data 2](#fig1sdata2){ref-type="supplementary-material"}. (**E**) Pumping rates of control and post-ARD animals. L4 and 3 weeks old ARD animals were scored about 1 hr after transfer to fresh OP50 plates. The same cohorts (control and post-ARD) were examined again 4 days later. Indicated are rates per minute. Shown are mean values ± SEM. See [Figure 1---source data 3](#fig1sdata3){ref-type="supplementary-material"}. (**F**) Thrashing rates (per minute) of control and post-ARD animals. Shown are mean values ± SEM. See [Figure 1---source data 4](#fig1sdata4){ref-type="supplementary-material"}. \*p\<0.05; \*\*p\<0.005; \*\*\*p\<0.0005.\
10.7554/eLife.36194.004Figure 1---source data 1.N2 lifespans.\
10.7554/eLife.36194.005Figure 1---source data 2.Body length.\
10.7554/eLife.36194.006Figure 1---source data 3.N2 pumping.\
10.7554/eLife.36194.007Figure 1---source data 4.N2 thrashing.](elife-36194-fig1){#fig1}

To dissect the mechanisms of post-ARD recovery, we first tested the model that signals from the germline to promote restoration of other tissues. The germline is a potent regulator of *C. elegans* longevity ([@bib5]). Regrowth of this tissue from a small pool of preserved stem cells is the most drastic morphological improvement associated with the diapause exit. We therefore hypothesized that the signals arising from the growing germline stimulate morphological restoration of somatic tissues as well. To test this model, we blocked germline re-growth with FUDR, a DNA synthesis inhibitor that is commonly used in *C. elegans* to chemically sterilize adult animals ([@bib14]).

We transferred either control L4 larvae or animals that had been maintained in ARD for 3 weeks onto fresh plates containing abundant *E. coli* OP50 food with or without 50 µM FUDR. While ARD animals recovered well in the absence of the drug, FUDR completely prevented germline regrowth or restoration of youthful morphology and functionality ([Figure 1A,B,D,E,F](#fig1){ref-type="fig"}). In addition, dead embryos were still present in the uterus of post-ARD animals on FUDR ([Figure 1A](#fig1){ref-type="fig"}, arrows). In contrast, FUDR did not have a strong effect on control L4 larvae, which progressed into adulthood ([Figure 1A](#fig1){ref-type="fig"}). We used body size increase, disappearance of dead embryos from the uterus, and overall visual improvements to score post-ARD recovery rates in subsequent experiments.

To test if post-ARD animals are more sensitive to chemical stresses in general, we analyzed recovery of post-ARD animals in the presence of hydroxyurea (HU). HU has a broad cytotoxic effect by acting on multiple targets, including reducing the availability of deoxynucleotides through inhibition of ribonucleotide reductase ([@bib41]; [@bib40]). While post-ARD animals showed only mild changes during morphological recovery in the presence of HU, control animals experienced rapid demise and collapse of body morphology within 4 days ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Therefore, the inhibitory effect of FUDR on post-ARD animals is not due to a general increase in sensitivity to chemicals.

We then tested how FUDR affects longevity of animals following exit from ARD. The drug is routinely used in lifespan experiments to prevent hatching of progeny and is typically applied at late L4 stage ([@bib14]; [@bib45]). To compare the effect of FUDR on young adult and ARD animals, we transferred animals to OP50 feeding plates prepared either with or without FUDR at either mid-L4 (when we would initiate ARD) or 3 weeks after entry into ARD. Despite the pronounced phenotypic difference produced by the drug following exit from ARD, the lifespans of both control and post-ARD animals on FUDR were not significantly different ([Figure 1C](#fig1){ref-type="fig"}). Therefore, FUDR prevents morphological restoration following exit from ARD without significantly impacting restoration of normal adult longevity, potentially uncoupling healthspan from lifespan.

The germline is dispensable for ARD entry and recovery {#s2-2}
------------------------------------------------------

To further test whether the effects of FUDR on recovery from ARD are due to inhibition of germline DNA synthesis, we used a worm strain carrying temperature-sensitive mutation in *glp-1*, which encodes a Notch receptor homolog essential for maintenance of the undifferentiated stem cells in the germline ([@bib6]). At the restrictive temperature, *glp-1(e2141)* animals develop into sterile adults that are virtually devoid of GSCs. If GSCs play an essential role in ARD, then *glp-1* mutants grown at the restrictive temperature should be unable to maintain or exit from the diapause state, and FUDR should not further impact *glp-1(e2141)* animals. Wild type N2 and *glp-1(e2141)* animals were raised at the restrictive temperature (25°C) and subjected to starvation at the L4 stage to induce ARD, which occurred normally in both genetic backgrounds. When animals were returned to fresh feeding plates to induce exit from ARD, both N2 and *glp-1(e2141)* animals resumed their growth, regained a youthful appearance, and restored pumping rate comparable to controls, indicating normal recovery ([Figure 2A,C](#fig2){ref-type="fig"}). Furthermore, post-ARD lifespans of the reproductively active N2 and sterile *glp-1(e2141)* animals after two weeks in ARD did not differ significantly from adult lifespans of the genetically matched controls that never experienced ARD ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). While we cannot rule out the possibility that *glp-1(e2141)* mutants may still have a small number of GSCs at the restrictive temperature, any remaining GSCs clearly fail to repopulate the germline. Therefore, we conclude that restoration of the germline is not required for the proper maintenance of, or recovery from ARD, and we find no evidence to support our prior model that signals from GSCs preserved during ARD mediate morphological and functional restoration and maintenance of full lifespan potential.

![Adult reproductive diapause does not require germline or cell cycle activation.\
(**A**) DIC images of ARD and post-ARD *glp-1 (e2141)* animals. FUDR prevented morphological improvements of the sterile *glp-1* mutants. Scale bar is 100 µm. (**B**) Survival curves of the wild type (WT) and *glp-1* mutants, control and post-ARD. On day 0, two weeks old ARD animals and control L4 were transferred onto fresh OP50. The next day was considered day1 of adulthood for both conditions. Shown are survival plots of recovered animals only. See [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}. Also see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**C**) Pumping rates (per minute) for control and post-ARD *glp-1 (e2141)* animals. Shown are mean values ± SEM. See [Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"}. (**D**) EdU labeling of control and post-ARD animals. Control animals were grown on EdU-labeled bacterial cells from egg till day 2 of adulthood. ARD animals were transferred on EdU-labeled cells for recovery and examined 5 days later. Arrows point to EdU-labeled germline cells nuclei, arrowheads point to EdU-labeled somatic nuclei. No somatic cells labeling was observed in post-ARD animals. Scale bar is 25 µm. (**E**) Ploidy (in diploid equivalents) of intestinal cells in ARD animals. Shown is the mean value ± SEM. See [Figure 2---source data 3](#fig2sdata3){ref-type="supplementary-material"}. (**F**) DIC images of ARD and post-ARD *cye-1 (eh10)* animals. FUDR prevented morphological improvements of *cye-1* mutants. Scale bar is 100 µm. (**G**) Pumping rates (per minute) of control and post-ARD *cye-1 (eh10)* animals. Shown are mean values ± SEM. See [Figure 2---source data 4](#fig2sdata4){ref-type="supplementary-material"}. (**H**) Fraction of *cye-1 (eh10)* animals that morphologically recovered after diapause with and without FUDR. Shown are mean values ± SEM. See [Figure 2---source data 5](#fig2sdata5){ref-type="supplementary-material"}. Also see [Figure 2---source data 6](#fig2sdata6){ref-type="supplementary-material"}. \*p\<0.05; \*\*p\<0.005; \*\*\*p\<0.0005.\
10.7554/eLife.36194.010Figure 2---source data 1.N2 and glp-1 lifespans.\
10.7554/eLife.36194.011Figure 2---source data 2.glp-1 pumping rate.\
10.7554/eLife.36194.012Figure 2---source data 3.Intestinal ploidy.\
10.7554/eLife.36194.013Figure 2---source data 4.cye-1 pumping.\
10.7554/eLife.36194.014Figure 2---source data 5.cye-1 recovery rate.\
10.7554/eLife.36194.015Figure 2---source data 6.N2 and glp-1 lifespans.](elife-36194-fig2){#fig2}

Although the germline is not necessary for ARD, it is still possible that FUDR blocks post-ARD recovery via its effect on the germline, for example by inducing a cell non-autonomous genotoxic stress signal in the germline that prevents morphological and functional restoration of somatic tissues. We therefore compared recovery of the sterile *glp-1(e2141)* animals with and without FUDR. As in wild type N2 animals, FUDR blocked the morphological and functional improvements upon exit from ARD in *glp-1(e2141)* animals ([Figure 2A,C](#fig2){ref-type="fig"}). Thus, we conclude that the effects of FUDR on ARD are unlikely to involve the germline or GSCs.

ARD recovery does not require activation of the cell cycle in somatic tissues {#s2-3}
-----------------------------------------------------------------------------

Since the inhibitory effect of FUDR was not due to its effect on the germline, we reasoned that post-ARD recovery may require activation of the cell cycle in somatic cells. For instance, it is possible that during progression from L4 to adulthood in the absence of nutrients, some somatic cell divisions or endoreduplications are postponed in ARD animals. In this scenario, completion of the skipped DNA replication cycles may be required for normal post-ARD recovery. To test this hypothesis, we examined synthesis of new DNA through metabolic labeling with 5-ethynyl-2'-deoxyuridine (EdU). When control animals are grown from egg to adulthood on EdU-labeled bacteria, birth of new DNA is observed both in germline and in somatic cells ([Figure 2D](#fig2){ref-type="fig"}). In contrast, EdU labeled only the germline in post-ARD animals ([Figure 2D](#fig2){ref-type="fig"}), suggesting that little or no additional DNA replication occurs in somatic tissues of post-ARD animals.

*C. elegans* are known to have polyploid tissues. For instance, intestinal cells normally undergo four rounds of endoreduplications with a final round of DNA synthesis during the molt from L4 to adulthood ([@bib17]). We were interested to examine if final intestinal endoreduplication is postponed during the diapause and only resumes during post-ARD recovery. However, we were unable to detect endoreduplication with EdU even in control animals grown on EdU-labeled bacteria from egg ([Figure 2D](#fig2){ref-type="fig"}), indicating that this method is not suitable for analysis of ploidy changes. Instead, to determine if intestinal cells need to undergo a round of endoreduplication upon post-ARD recovery, we estimated ploidy of intestinal cells in ARD animals using DAPI staining. We found that intestinal nuclei in ARD animals contain approximately 16 equivalents of diploid genomes, indicating that these cells have already completed endoreduplications prior to exit from ARD ([Figure 2E](#fig2){ref-type="fig"}).

To directly test whether cell cycle activation in somatic tissues is required during exit from ARD, we analyzed post-ARD recovery of cyclin E-deficient animals and their sensitivity to FUDR. *cye-1(eh10)* animals are maintained as a heterozygous strain with a balancer chromosome. Homozygous *cye-1(eh10)* mutants are viable, but do not complete endoreduplications, have smaller body size and defects in the development of reproductive system ([@bib30]). We found that somatic tissues of homozygous *cye-1 (eh10)* animals recover from ARD normally and that this recovery is blocked by FUDR ([Figure 2F,G,H](#fig2){ref-type="fig"}). Therefore, reactivation of cell cycle (or endocycle) is not required for post-ARD recovery.

Mitochondrial DNA replication is not required for recovery from ARD {#s2-4}
-------------------------------------------------------------------

Neither germline nor somatic nuclear DNA synthesis were required for post-ARD recovery, hence we speculated that inhibition of somatic mitochondrial DNA replication might underlie the inhibitory effects of FUDR in this context. To test this possibility, we utilized a strain homozygous for a loss of function allele of the mitochondrial DNA polymerase gene *polg-1*. Homozygous *polg-1(ok1548)* mutants are viable and develop into morphologically normal adults, but are sterile and only produce a few inviable progeny ([@bib8]). The strain is maintained with a balancer chromosome containing a wild type copy of *polg-1*. For these experiments, we used a strain in which the balancer chromosome carries the fluorescent marker *myo-2::GFP* expressed in the pharynx. We compared post-ARD recovery in *polg-1(ok1548/+)* heterozygotes and *polg-1(ok1548)* siblings that can be distinguished by the presence of the fluorescent marker ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Consistent with the requirement for mitochondrial DNA synthesis for germline formation, homozygous *polg-1* mutants did not re-grow their germline after recovery from ARD ([Figure 3A](#fig3){ref-type="fig"}, arrow). However, we did not observe any other morphological defects in post-ARD *polg-1* mutants when compared to heterozygous siblings ([Figure 3A](#fig3){ref-type="fig"}). Similar fractions of *polg-1(ok1548/+)* and *polg-1(ok1548)* animals recovered in all the experiments ([Figure 3D](#fig3){ref-type="fig"}). In addition, we examined mitochondrial DNA content in ARD and post-ARD animals using qPCR. We again utilized sterile *glp-1(e2141)* animals to only analyze somatic cells. As shown in [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}, we did not detect any increase of mitochondrial DNA content during post-ARD recovery. Therefore, synthesis of new mitochondrial DNA is not required for somatic recovery after ARD.

![RNA, but not DNA, metabolism is required for post-ARD recovery.\
(**A**) DIC images of *polg-1 (ok1548/+)* heterozygotes and *polg-1 (ok1548)* mutants. Animals spent 3 weeks in the diapause and were then allowed to recover for 4 days on fresh OP50 plates. Arrows point to newly produced eggs in case of *polg-1 (ok1548/+)* heterozygotes and to non-recovered germline in case of *polg-1 (ok1548)* mutants. Scale bar is 100 µm. (**B**) DIC images of post-ARD animals recovering on 50 µM FUDR, 50 µM FUDR +1 mM uracil and 50 µM FUDR +1 mM thymine. Uracil, but not thymine rescued growth and recovery of post-ARD animals in presence of FUDR. Scale bar is 100 µm. (**C**) DIC images of post-ARD animals recovering on NGM plates containing 25 µM FUDR and seeded with different bacterial cells from Keio knockout collection. Control diet -- BW25113, *Δtdk* -- JW1226-1, *Δupp* -- JW2483-1. Inhibitory effect of FUDR was reduced by JW2483-1 cells. Scale bar is 100 µm. (**D**) Fraction of *polg-1 (ok1548/+)* and *polg-1 (ok1548)* animals that morphologically recovered after ARD. Shown are mean values ± SEM. See [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}. (**E**) Fractions of animals that morphologically recovered after ARD in various conditions (see [Figure 3B](#fig3){ref-type="fig"}). Shown are mean values ± SEM. See [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}. (**G**) Fractions of animals that morphologically recovered after ARD with different bacterial diets in presence of FUDR (see [Figure 3C](#fig3){ref-type="fig"}). Shown are mean values ± SEM. See [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}. \*p\<0.05; \*\*p\<0.005; \*\*\*p\<0.0005.\
10.7554/eLife.36194.019Figure 3---source data 1.polg-1 recovery rate.\
10.7554/eLife.36194.020Figure 3---source data 2.Recovery with uracil.\
10.7554/eLife.36194.021Figure 3---source data 3.Recovery with bacterial mutants.\
10.7554/eLife.36194.022Figure 3---source data 4.mtDNA content.\
10.7554/eLife.36194.023Figure 3---source data 5.Recovery with uridine.](elife-36194-fig3){#fig3}

RNA, but not DNA, metabolism is required for recovery from ARD {#s2-5}
--------------------------------------------------------------

Neither germline nor somatic DNA synthesis could explain the ability of FUDR to block post-ARD recovery. We therefore considered the alternative possibility that FUDR acts on post-ARD recovery by inhibiting RNA metabolism. While both FUDR and the related compound 5-fluorouracil (5-FU) were long thought to only inhibit DNA synthesis, recent evidence suggests an RNA-targeted mechanism of toxicity of 5-FU ([@bib15]; [@bib10]; [@bib19]; [@bib20]). We therefore tested whether supplementation of extra DNA or RNA nucleotides could suppress FUDR toxicity in the context of ARD. Uracil, but not thymine, largely rescued post-ARD recovery in the presence of FUDR ([Figure 3B](#fig3){ref-type="fig"}), with a majority of FUDR-treated animals able to undergo recovery upon uracil supplementation ([Figure 3E](#fig3){ref-type="fig"}). Similarly, the inhibitory effect of FUDR was suppressed by uridine, but not thymidine ([Figure 3---figure supplement 1C,D](#fig3s1){ref-type="fig"}). Deoxyuridine also rescued post-ARD recovery ([Figure 3---figure supplement 1C,D](#fig3s1){ref-type="fig"}); however, interpretation of this experiment is difficult due to the fact that deoxyuridine may compete with FUDR (5-fluoro-2'-deoxyuridine) for the same targets and interfere with FUDR metabolism in the animal.

Recent reports indicated that bacterial metabolism affects the response to FUDR in *C. elegans* ([@bib15]; [@bib37]). To further distinguish between requirements for RNA versus DNA metabolism in recovery of post-ARD animals, we utilized bacterial mutant strains deficient in nucleotide-processing enzymes. Namely, we used strains JW1226-1 (deficient in thymidine kinase, *Δtdk*), JW2483-1 (deficient in uracil phosphoribosyltransferase, *Δupp*) and BW25113 (parent strain, control diet) from the Keio collection. We expected FUDR toxicity to be reduced by JW2483-1 compared to parent strain BW25113, due to the inability of this strain to efficiently incorporate FUDR derivatives into RNA metabolism. In contrast, we expected that loss of *tdk* would not affect sensitivity of post-ARD animals to FUDR. As shown in [Figure 3C,F](#fig3){ref-type="fig"} the inhibitory effect of FUDR was indeed reduced by JW2483-1 (*Δupp*), but not JW1226-1 (*Δtdk)* compared to the parent strain BW25113.

In addition, we examined a worm strain carrying a temperature sensitive allele of thymidine synthase *tyms-1(hc65)*. TYMS-1 is one of the targets of FUDR that mediates its DNA-based toxicity ([@bib49]; [@bib35]). Animals homozygous for the *tyms-1(hc65)* allele recovered normally from ARD at the restrictive temperature ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Taken together, these observations support the model that FUDR prevents post-ARD recovery through inhibition of RNA metabolism.

Nucleolar expansion is an early step in post-ARD recovery {#s2-6}
---------------------------------------------------------

5-FU exerts its anti-cancer activity at least in part through inhibition of ribosomal RNA (rRNA) production and induction of ribosomal stress ([@bib10]; [@bib11]; [@bib42]; [@bib44]). Therefore, the strong inhibitory effect of FUDR on post-ARD animals may result at least partially from suppression of rRNA biogenesis. To examine the impact of ARD and FUDR on rRNA metabolism, we first examined nucleolar morphology ([@bib47]). Synthesis and processing of rRNA occur in the nucleolus, a phase separated organelle inside the nucleus, which is organized around rDNA repeats encoding the rRNA. To track nucleolar status, we used a transgenic strain producing GFP-tagged homologue of fibrillarin (FIB-1), a nucleolar methyltransferase involved in post-transcriptional rRNA processing.

Examination of ARD animals revealed that their nucleoli were dramatically smaller than in control L4 larvae or young adults ([Figure 4A,C](#fig4){ref-type="fig"}). When animals exited ARD, their nucleoli rapidly increased in size and reached a size similar to that of young, well-fed controls. FUDR did not prevent the nucleolar expansion upon exit from ARD ([Figure 4A,C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), suggesting that early steps of nucleolar reactivation may not be impaired by the drug. This interpretation is complicated somewhat by the unexpected finding that FUDR caused a pronounced expansion of nucleoli in control animals that had never experienced ARD ([Figure 4A,C](#fig4){ref-type="fig"}). These effects were independent of the germline ([Figure 4B,D](#fig4){ref-type="fig"}) and were reduced by addition of uracil to the growth medium ([Figure 4A,C](#fig4){ref-type="fig"}). Thus, we conclude that FUDR affects nucleolar structure in somatic post-mitotic tissues of wild type animals.

![Post-ARD recovery is associated with nucleolar expansion.\
(**A**) Representative images of nucleolar morphology. Shown are nucleoli of intestinal cells visualized with fib-1::GFP. Control L4 and ARD animals were imaged before transfer to fresh OP50 plates containing no FUDR, 50 µM FUDR and 50 µM FUDR +1 mM uracil (F + U). Animals were then analyzed 4 days after transfer. Top panel: control animals at L4 stage and at 4 days of adulthood. Bottom panel: ARD animals before and after 4 days of recovery with or without FUDR. (**B**) FUDR induces nucleolar stress in post-mitotic tissues independently of the germline. Wild type and sterile *glp-1* mutants were grown at restrictive temperature (25°C) until day 1 of adulthood and then transferred onto FUDR-containing plates and analyzed 3 days later. (**C**) Quantification of nucleolar size from intestinal cells (in μm^2^) of animals treated as in 4A. Shown are mean values ± SEM. See [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}. (**D**) Quantification of nucleolar size from intestinal nucleoli (in μm^2^) of animals treated as in 4B. Shown are mean values ± SEM. See [Figure 4---source data 2](#fig4sdata2){ref-type="supplementary-material"}. Also see [Figure 4---source data](#fig4sdata1){ref-type="supplementary-material"} . \*p\<0.05; \*\*p\<0.005; \*\*\*p\<0.0005. Scale bar is 10 µm.\
10.7554/eLife.36194.026Figure 4---source data 1.Post-ARD nucleolar size.\
10.7554/eLife.36194.027Figure 4---source data 2.\
10.7554/eLife.36194.028Figure 4---source data 3.Nucleolar size, AL condition.](elife-36194-fig4){#fig4}

FUDR impairs post-ARD expansion of the cellular RNA pool and rRNA processing {#s2-7}
----------------------------------------------------------------------------

To better understand the changes in cellular RNA landscape associated with post-ARD recovery and FUDR treatment, we analyzed total RNA, as well as rRNA, in control and post-ARD animals. To focus only on somatic tissues, we used sterile *glp-1(e2141)* worms grown at the restrictive temperature. Total RNA was extracted from post-ARD animals and analyzed on an Agilent TapeStation system ([Figure 5A](#fig5){ref-type="fig"}). It was immediately apparent that FUDR impairs expansion of total RNA upon exit from ARD, as approximately 3.5-fold more FUDR-treated animals were needed to obtain comparable loading on the gel. Quantitatively, we found that animals not treated with FUDR expand their RNA content around 20-fold during exit from ARD, while FUDR almost completely prevented this RNA pool expansion ([Figure 5B](#fig5){ref-type="fig"}). This defect was mostly suppressed by uracil supplementation ([Figure 5B](#fig5){ref-type="fig"}). As shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, the overall RNA landscape looked similar in all conditions, pointing to strong inhibition of all RNA species by FUDR. Based on these observations, we propose that a strong inhibitory effect of the drug on RNA metabolism underlies its effect on post-ARD recovery.

![Expansion of the RNA pool during post-ARD recovery.\
(**A**) Total RNA extracted from post-ARD animals recovering in various conditions: no FUDR, 50 µM FUDR +1 mM uracil (F + U), 50 µM FUDR and ARD animals before recovery. Around 500 animals were used for no FUDR and FUDR +uracil sample preps, 3.5-fold more animals (around 1750) were used for FUDR and ARD preps. F + U and no FUDR samples were diluted 5-fold more than FUDR and ARD samples to fit into the quantitative range of TapeStation System. (**B,C,D**) Quantification of conditions shown in 5A. Normalized total RNA content (**B**), fraction of rRNA species in the total analyzed RNA, % (**C**) and ratio of 28S to 18S rRNA abundances (**D**). Shown are mean values ± SEM. Total RNA content was calculated from the TapeStation and adjusted to reflect dilution factor and number of animals (total RNA per animal). Values are expressed as % of RNA content in no FUDR sample, which was set as 100%. See [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}. (**E**) Total RNA extracted from control animals that were transferred on fresh OP50 plates with or without FUDR at L4 stage. Around 300 animals were used per prep. (**F, G, H**) Quantification of conditions shown in 5E. Total RNA content (**F**), fraction of rRNA species in the total analyzed RNA, % (**G**), ratio of 28S to 18S rRNA abundances (**H**). Total RNA content is presented similarly to [Figure 5B](#fig5){ref-type="fig"}. Values are expressed as % of RNA content in no FUDR sample, which is set as 100%. All values are means ± SEM. See [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}. \*p\<0.05; \*\*p\<0.005; \*\*\*p\<0.0005.\
10.7554/eLife.36194.031Figure 5---source data 1.RNA analysis.](elife-36194-fig5){#fig5}

We also specifically examined changes to rRNA in these conditions. FUDR caused a decrease in rRNA abundance (relative to total RNA) ([Figure 5C](#fig5){ref-type="fig"}) and the 28S/18S rRNA ratio ([Figure 5D](#fig5){ref-type="fig"}). This is consistent with a previous report that processing of the 28S rRNA is more sensitive to 5-FU than processing of 18S rRNA ([@bib25]). We also noticed the appearance of unprocessed rRNA precursors in animals treated with FUDR ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, arrow); however, the small magnitude of effect makes it difficult to evaluate significance of the phenomenon. These effects of FUDR on rRNA were also suppressed by addition of uracil.

In addition, we analyzed the effect of FUDR on RNA profile in adult control *glp-1(e2141)* animals that never experienced ARD ([Figure 5E](#fig5){ref-type="fig"}). We observed a trend toward reduction of total RNA and rRNA/total RNA ratio upon FUDR treatment, although these effects did not reach statistical significance ([Figure 5F,G](#fig5){ref-type="fig"}). These results are consistent with the much less pronounced effect of the drug on well-fed control animals ([Figure 1](#fig1){ref-type="fig"}). We did however observe a modest but statistically significant effect of FUDR on 28S/18S ratio in control animals ([Figure 5H](#fig5){ref-type="fig"}), suggesting that rRNA metabolism may still be affected by the drug in control animals.

Discussion {#s3}
==========

The phenomenon of *C. elegans* ARD provides an attractive opportunity to investigate how functionality of chronologically old tissues can be maintained or improved. The work described here indicates that restoration of somatic tissues and normal lifespan upon diapause exit occurs even in the absence of a functional germline or GSCs, indicating that signals arising from GSCs are unlikely to be causative for these effects. Moreover, restoration of somatic tissues does not require somatic cell divisions, mitochondrial replication, or cell cycle activation. Instead, our data support a model that exit from ARD involves early nucleolar reactivation, followed by a burst of rRNA production and subsequent amplification of total cellular RNA. It seems likely that this is necessary for the synthesis of new cellular material which is important for restoration of youthful structure and function. The drug FUDR interferes with nucleolar function, rRNA processing, and total RNA production and prevents morphological and functional somatic recovery upon exit from ARD.

Our findings point to rRNA production in particular as a key intracellular mediator of ARD maintenance and recovery. The nucleolus ([@bib16]; [@bib27]) and rDNA ([@bib39]; [@bib23]) were identified in early studies as key sub-cellular sites for longevity control in yeast, and more recent reports have indicated the importance of nucleolar plasticity in longevity of *C. elegans*, with smaller nucleoli being associated with longer lifespan ([@bib9]; [@bib46]). Consistent with this, we find that nucleoli are markedly smaller during ARD, while exit from ARD is associated with nucleolar expansion and amplification of the rRNA pool. In this regard, it is interesting that FUDR blocked the increase in rRNA upon exit from ARD but did not fully prevent expansion of the nucleolus, demonstrating that nucleolar size alone does not always reflect rRNA abundance and ribosome biogenesis. The nucleolus is a dynamic organelle that houses various enzymes for RNA processing and its composition is responsive to cellular stresses ([@bib7]). Therefore, one potential explanation for our results is that nucleolar size may be driven by early recruitment of rRNA-processing enzymes such as FIB-1 along with other machinery needed for ribosome biogenesis, and this step is not blocked by the drug. Alternatively, the increase of nucleolar size in post-diapause animals may reflect a compensatory response to impaired rRNA production caused by the drug, as we have observed that *ad libitum* fed control animals have larger nucleoli following treatment with FUDR.

A particularly striking feature of this study is the dramatic expansion of both rRNA and total RNA in post-ARD animals which is nearly completely prevented by treatment with FUDR. While this makes it difficult to pinpoint whether specific RNA species are most important for morphological and functional restoration post-ARD, we speculate that the decreased rRNA content and abnormal ratio of 28S/18S rRNA species are important, as these defects are likely to lead to impaired ribosome biogenesis and global mRNA translation. In particular, defects in ribosome biogenesis could drive the failure to expand the total mRNA due to reduced translation of transcriptional machinery. We also note that FUDR had a much smaller impact on the RNA content of somatic tissues in fully developed *ad libitum* fed adult animals, causing a trend toward reduced total RNA content and rRNA/total RNA ratio and a modest but significant reduction in 28S/18S rRNA ratio. These less pronounced effects of FUDR likely reflect that fact that somatic cells in adult animals are not undergoing the rapid growth and remodeling associated with exit from ARD, and therefore do not require as much new ribosome biogenesis and total mRNA production. Further studies will be needed to test these ideas.

Based on our observations, we speculate that normal longevity and post-diapause recovery may be regulated by distinct mechanisms. Metabolic attenuation, small nucleolar size, and stress resistance, perhaps similar to that associated with dietary restriction, are important both for survival during ARD as well as for long adult lifespan during normal aging. In contrast, somatic recovery and growth upon exit from ARD are associated with a rapid metabolic burst and associated amplification of rRNA and total RNA to support new protein synthesis. In this regard, it is interesting to note that intermittent fasting regimens where adult animals are subjected to periods of fasting intermixed with periods of *ad libitum* feeding have been found to increase lifespan in *C. elegans* ([@bib47]; [@bib18]) and mice ([@bib31]; [@bib50]). It will be of interest to determine whether these types of regimens induce repeated cycles of nucleolar activation and contraction at the subcellular level and, if so, how this relates to metabolic activation and cellular restoration.

Although we are beginning to understand the cell-autonomous mechanisms of post-diapause recovery, the early signals that induce exit from ARD remain largely unknown. Likewise, the impact of specific tissues on whole-animal ARD recovery remains to be determined. For example, it may be that functional restoration of the pharynx and intestine are necessary for sufficient nutrient uptake to support restoration of the rest of the animal. The data presented here do demonstrate that successful transduction of this signal does not require a functional germline. Experimentally, exit from ARD is accomplished by providing the worms with bacterial food, so presumably food sensory pathways are transducing a pro-growth recovery signal from sensory neurons to somatic cells. Prior work has implicated both soluble and volatile food cues ([@bib43]) along with neuronal serotonergic signaling in cell non-autonomous pro-longevity mechanisms ([@bib29]; [@bib32]; [@bib33]). It will be of interest to determine whether similar pathways become engaged during exit from ARD to promote growth and restore somatic tissues.

Finally, our work may shed light on the molecular mechanism of action of FUDR and, in particular, the inconsistent effects of FUDR on *C. elegans* lifespan and healthspan, as reported by a growing number of studies ([@bib48]; [@bib1]; [@bib15]; [@bib26]; [@bib2]; [@bib3]). It has been assumed that these effects were the result of FUDR inhibiting DNA synthesis and reproduction, but our results point to a potentially important role for inhibition of RNA metabolism, including maturation of rRNA. Inhibition of RNA production by FUDR could exert broad effects on protein synthesis and cellular metabolism, particularly in cells or tissues undergoing growth or remodeling, or in genetic backgrounds that are particularly sensitive to perturbations in ribosome function or RNA metabolism. These effects should be considered, and when possible quantified, in future studies using FUDR.

It is of particular interest that FUDR prevented the functional and morphological restoration of post-ARD animals while having no detectable effect on restoration of full adult lifespan. This observation suggests that FUDR somehow uncouples healthspan from lifespan in post-ARD animals. The mechanism behind this uncoupling remains mysterious, but may provide a useful model for future studies aimed at understanding the mechanistic relationships between lifespan and healthspan. Such an understanding may be critical for development and implementation of interventions aimed at reducing morbidity and mortality in the aging populations.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\            Designation             Source or reference         Identifiers           Additional information
  or resource                                                                                                  
  ---------------------------------- ----------------------- --------------------------- --------------------- ------------------------
  Material and me strain,\           glp-1 (e2141); glp-1    CGC                         CGC: CB4037           
  strain background (*C. elegans*)                                                                             

  Strain, strain background\                                 CGC                         CGC: DR2078           
  (*C. elegans*)                                                                                               

  Strain, strain background\                                 CGC                         CGC: VC1224           
  (*C. elegans*)                                                                                               

  Strain, strain background\         polg-1 (ok1548);\       This study                                        Cross of DR2078\
  (*C. elegans*)                     polg-1 (ok1548/+)                                                         and VC1224

  Strain, strain background\         fib-1::GFP              CGC                         CGC: COP262           
  (*C. elegans*)                                                                                               

  S*train, strain background*\       tyms-1                  CGC                         CGC: MJ65             
  (*C. elegans*)                                                                                               

  Strain, strain background\         cye-1; cye-1 (eh10)     CGC                         CGC: KM166            
  (*C. elegans*)                                                                                               

  Strain, strain background\         MG1693 (Δthy)           E. coli\                    CGSC\#: 6411          
  (*E. coli)*                                                Genetic Resources at Yale                         

  Strain, strain background\         parent strain;\         E. coli\                    CGSC\#: 7636          
  (*E. coli)*                        control diet; BW25113   Genetic Resources at Yale                         

  Strain, strain background\         Δtdk; JW1226-1          E. coli\                    CGSC\#: 9112          
  (*E. coli)*                                                Genetic Resources at Yale                         

  Strain, strain background\         Δupp; JW2483-1          E. coli\                    CGSC\#: 9982          
  (*E. coli)*                                                Genetic Resources at Yale                         

  Chemical compound, drug            5-Ethynyl-2\'-\         Invitrogen                  ThermoFisher:\        
                                     deoxyuridine, EdU                                   C10339                

  Chemical compound, drug            Uracil, U               Alfa Aesar                  Fisher scientific:\   
                                                                                         AAA1557018            

  Chemical compound, drug            Uridine, Urd            Alfa Aesar                  Fisher scientific:\   
                                                                                         A1522706              

  Chemical compound, drug            Thymine, T              Acros\                      Fisher scientific:\   
                                                             Organics                    AC157850050           

  Chemical compound,\                Thymidine, Thd          Alfa Aesar                  Fisher scientific:\   
  drugMaterial and me                                                                    A1149306              

  Chemical compound, drug            Deoxyuridine, dUrd      Alfa Aesar                  Fisher scientific:\   
                                                                                         A1602603              

  Commercial assay or kit            High Sensitivity\       Agilent                     Agilent: 5067--\      
                                     RNA ScreenTape\                                     5581                  
                                     Ladder                                                                    

  Commercial assay or kit            High Sensitivity\       Agilent                     Agilent: 5067--\      
                                     RNA ScreenTape\                                     5580                  
                                     Sample Buffer                                                             

  Commercial assay or kit            High Sensititive\       Agilent                     Agilent: 5067--\      
                                     RNA ScreenTape                                      5579                  

  Sequence-based reagent             nd1 forward             IDT                                               AGCGTCATTTATTG\
                                                                                                               GGAAGAAGAC

  Sequence-based reagent             nd1 reverse             IDT                                               AAGCTTGTGCTAAT\
                                                                                                               CCCATAAATGT
  -------------------------------------------------------------------------------------------------------------------------------------

*C. elegans* strains and maintenance conditions. {#s4-1}
------------------------------------------------

The following strains were used in this study: N2, CB4037 (*glp-1 (e2141)*), DR2078 (*mIn1 \[dpy-10(e128) mIs14\]/bli-2(e768) unc-4(e120) II*), VC1224 (*Y57A10A.15(ok1548)/mT1 II; +/mT1 \[dpy-10(e128)*\] II), COP262 (*knuSi221 \[fib-1p::fib-1(genomic)::eGFP::fib-1 3\' UTR + unc-119(+)\]*), MJ65 (*tyms-1(hc65) I*), KM166 (*cye-1(eh10)*). All strains were obtained from CGC. VC1224 and DR2078 were mated to introduce GFP-marked balancer chromosome into VC1224 background. COP262 was mated with CB4037 to analyze nucleolar dynamics in sterile animals. Animals were maintained at 20°C on NGM plates seeded with live *E. coli* unless otherwise indicated. Experiments with *glp-1 (e2141)* mutants were performed at 25°C to prevent germline development.

Induction of and recovery from adult reproductive diapause {#s4-2}
----------------------------------------------------------

Adult reproductive diapause was initiated as described previously ([@bib4]) . Briefly, hypochlorite-synchronized animals were allowed to grow until early mid-L4 stage on live OP50 *E. coli.* Developmental stage was assessed by the growth of germline and vulva development ([@bib13]; [@bib48]) using dissecting and DIC microscopes. Sterile *glp-1* mutants were staged by vulva development. Animals were then gently washed off the plates into 15 ml Falcon tubes using M9 buffer with 0.1% Tween 20 (M9-Tw). After short centrifugation at 400 g, supernatant was removed, and fresh M9-Tw was added. Washing was repeated at least five times after which animals were transferred onto non-seeded NGM plates (BD plates) for starvation. BD plates were prepared as described previously ([@bib4]) but supplemented with 50 µg/ml of carbenicillin. Animals were maintained on BD plates at 20°C in most of the experiments. All strains were grown and maintained at 25°C in experiments with *glp-1* mutants. Plates were examined regularly to spot potential contamination in which case plates were discarded.

For recovery from ARD, animals were gently washed off the BD plates with M9-Tw and transferred onto fresh NGM plates seeded with live OP50 *E. coli* and containing appropriate additives (50 μM FUDR, 1 mM uracil, 1 mM thymine, 40 mM hydroxyurea, 1 mM uridine, 1 mM deoxyuridine, 1 mM thymidine). Non-adult animals (larvae born during starvation and L4 larvae that did not reach adulthood) were manually removed under a dissecting microscope. Remaining animals were used for subsequent experiments (morphological analysis, lifespans, microscopy, health measures). Animal was considered recovered from diapause if it displayed visual improvements compared to starved animals (body size, intestine coloration, germline growth (for non-sterile strains), motility). *Ad libitum* fed L4 controls were transferred onto identical plates at the same developmental point at which ARD was usually initiated.

We used strains from the Keio *E. coli* deletion collection to analyze effect of bacterial diet on FUDR toxicity during post-ARD recovery. BW25113 (parent strain of the collection), JW1226-1 (*Δtdk*) and JW2483-1 (*Δupp*) cells were grown in LB media overnight and seeded on NGM plates containing 25 µM FUDR. Plates were allowed to dry for 2 days before experiment. ARD animals were transferred on the plates and scored for recovery as in other conditions.

Three independent biological replicates were performed to assess post-ARD recovery in each examined condition. We typically analyzed few to several dozen animals per condition in one experiment. Also see supporting file with detailed numerical data. Bar graphs in the figures show mean ± SEM calculated from recovery rates in 3 biological replicates.

Lifespan assay {#s4-3}
--------------

For lifespan assays ([@bib45]), animals were transferred onto fresh plates every 2--3 days until reproduction had ceased, and then upon necessity to prevent food depletion. When FUDR was used, animals were transferred as necessary to prevent food exhaustion. To score viability, immobile animals were gently probed with a platinum wire. Animals that crawled off the plate and did not return and animals that died from internal progeny hatching were excluded from analysis. We typically started with 3 plates (with 40--45 animals per plate) per condition. Three independent biological replicates were performed for each lifespan experiment. Figures show results of individual representative experiments.

Pumping and thrashing rate measurements {#s4-4}
---------------------------------------

To analyze pumping rate, animals were observed under a dissecting microscope for 15--30 s, and the number of terminal bulb movements was recorded. We typically scored 10 animals per condition and calculated mean values ± SEM. Values are expressed as pumping rate per minute. Bar graphs in the figures show mean ± SEM from individual representative experiments.

For thrashing assays, animals were carefully transferred into a drop of clean M9 and the number of body bends during a 15--30 s observation period was recorded. We typically scored 10 animals per condition and calculated mean values ± SEM. Values are expressed as rate per minute.

Three independent biological replicates were performed for each pumping and thrashing measures presented. In case of thrashing assay, figures show mean ± SEM calculated for combined pool of animals from all three experiments.

Microscopy {#s4-5}
----------

DIC and fluorescence images were acquired using a Zeiss Axiovert Compound Microscope and a Zeiss LSM780 Confocal Microscope. Animals were placed on 1% agarose pads and anesthetized with 0.2% tricaine/0.02% tetramisole solution. To visualize the germline, animals were fixed for 20 min in ice cold EtOH and stained with 4\',6\'-diamidino-2-phenylindole hydrochloride (DAPI) in M9-Tw.

For nucleoli analysis, we specifically examined intestinal cells using a confocal microscope using 40 × 1.2 NA water immersion objective. We set up optical slice thickness to 1 micrometer. We scored between 30--50 nucleoli from 5 to 10 animals per group for average size determination (shown are means ± SEM). We measured nucleolar size using ImageJ ellipse and free hand selection tools. Three independent biological replicates were performed for analysis of nucleolar changes. Bar graphs in the figures show mean ± SEM from individual representative experiments.

For simultaneous analysis of nucleolar and nuclear sizes, ARD and post-ARD animals were fixed in EtOH and stained with DAPI in M9-Tw. Animals were then imaged with 2 µm optical slices. Two independent biological replicates were performed. Around 20 nuclei/nucleoli pairs were examined in each experiment. Bar graphs in the figures show mean ± SEM from a representative experiment.

For estimation of ploidy, DAPI-stained animals were imaged on Zeiss LSM780 Confocal Microscope with 2 µm optical slices and 2 µm steps between slices. For each intestinal nucleus its DAPI signals from several slices were summed up and normalized for DAPI signals of diploid somatic or mitotic germline cells lying at the approximately same depth. The resulting values are therefore expressed as diploid equivalents. Two independent biological replicates were performed. A total of around 10 intestinal nuclei from 5 animals were examined in each trial. Bar graphs in the figures show mean ± SEM from a representative experiment.

EdU labeling {#s4-6}
------------

To visualize newly synthesized DNA, MG1693 (*Δthy*) cells were grown in LB media overnight. 4 ml of the overnight culture was inoculated into 100 ml of M9 media supplemented with 5 ml of 20% glucose, 400 µl of 1.25 mg/ml thiamine, 5 µl of 10 mM thymidine, 100 µl 1M MgSO4, 100 µl 20 mM 5-ethynyl-2'-deoxyuridine (EdU). Cells were grown for additional 24 hr, concentrated by centrifugation and seeded on M9 agar plates. Cells were allowed to dry for 2 days and then used for experiments or stored at 4°C. Control animals were grown on EdU-labeled cells from egg till day 2 of adulthood. ARD animals were transferred on EdU-labeled cells for recovery and analyzed 5 days later.

For imaging, animals were washed in M9-Tw and fixed in ice-cold methanol. Click-labeling with Alexa-594 was then performed following manufacturer protocol (Invitrogen). Animals were also stained with DAPI. DAPI/Alexa-labeled animals were then examined using Zeiss LSM780 Confocal Microscope. We have performed two independent biological replicates with EdU labeling.

Determination of mitochondrial DNA copy number {#s4-7}
----------------------------------------------

To measure mtDNA content we followed previously described qPCR approach ([@bib8]; [@bib34]). Briefly, individual *glp-1 (e2141)* animals (L1 larvae, ARD and post-ARD) were lysed by proteinase K digestion in 10 µL lysis solution (1 mg/ml proteinase K, 30 mM Tris pH8.0) for 25 min at 60°C. After inactivation of the proteinase K at 95°C samples were diluted up to 20 µL and used for qPCR reaction for NADH dehydrogenase subunit 1 (nd1) as described before ([@bib8]; [@bib34]). Three independent biological replicates were performed for qPCR measurements. In each experiment we analyzed 8 individual animals per condition with 3 technical replicates for each sample. Samples that did not amplify were not included into the analysis. Bar graphs in the figures show mean ± SEM from a representative experiment.

Total RNA analysis {#s4-8}
------------------

Age-synchronized adult animals were washed at least six times in M9-Tw and then incubated in the same buffer for about 20 min to allow clearance of gut bacteria. Animals were washed one more time after that and transferred to TRIzol solution (Invitrogen). Total RNA was extracted using a Qiagen RNeasy kit following manufacturer recommendations. RNA concentration was first measured on Thermo NanoDrop spectrophotometer, and sample concentrations were adjusted to fit into quantitative range of the Agilent TapeStation. Total RNA, rRNA content, as well as RNA profiles were then analyzed using the Agilent 4200 TapeStation System using High Sensititive RNA ScreenTape following manufacturer protocols. Approximately 500 post-ARD animals per group were used in no FUDR and FUDR +uracil conditions, and 3.5-fold more animals were used in post-ARD FUDR and ARD conditions. We used approximately 300 animals per prep when analyzing the effect of FUDR on control animals. Total RNA content is normalized for the number of animals used in each prep and expressed as % of RNA content in the control (FUDR-free) sample, which is set as 100%.

Three independent biological replicates were performed with ARD animals. Two independent biological replicates were performed with control animals. Bar graphs in the figures show mean ± SEM from individual representative experiments.

Statistical analysis {#s4-9}
--------------------

All the quantitative data were presented as means ± SEM. We performed comparison between groups using student t-test. P values less than 0.05 were considered significant (marked by \* on bar graphs). P values less than 0.005 and 0.0005 were marked by \*\* and \*\*\* respectively.
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Thank you for submitting your article \"Reactivation of somatic RNA metabolism mediates morphological rejuvenation after *C. elegans* adult reproductive diapause\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kevin Struhl as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Scott Kennedy (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Below are the reviews presented first, followed by the reviewer discussion, where the reviewers had other suggestions. As you can see, there is ample support for publishing this paper but some simple suggested experiments. The reviewers were mindful to not request inordinately laborious experiments or experiments that would constitute the next paper in this analysis; their suggestions were reasonable.

Reviewer \#1:

In this manuscript by Burnaevskiy et al., the authors explore how *C. elegans* recover from starvation-induced adult reproductive diapause (ARD). The story begins with the observation that the nucleotide analog FUDR prevents recovery from ARD. Genetic studies suggest that the role of FUDR in ARD recovery is independent of the germline. Additionally, the authors find that, during ARD recovery, RNA metabolism is activated (\~20x). Surprisingly, FUDR blocks this activation. Finally, the authors show that the effects of FUDR on ARD recovery (as well as RNA activation) can be suppressed by uracil, suggesting that RNA activation is required for ARD recovery and that the effects of FUDR on ADR are caused by FUDR\'s ability to prevent RNA activation. The methodology used in the paper seems sound and, for the most part, conclusions were justified by the data (see below). While it is not altogether surprising to me that RNA metabolism would need to be activated for animals to recover from ARD, the authors do a good job of establishing the point. In this regard, the uracil rescue experiment described in Figure 3D was particularly elegant and convincing. Additionally, it was quite surprising to me that FUDR would play such a pronounced role in RNA activation post-ARD, a factoid I suspect will be of interest to other researchers that use, or have used, FUDR in their experiments. For these reasons, I recommend publishing the work in *eLife*. Below, I list some suggestions that may improve the manuscript.

1\) Attempts to link the ideas of tissue rejuvenation after ARD and tissue rejuvenation after aging felt shoehorned to me. I would guess that recovery from acute starvation and recovery from the damage of long-term aging are going to end up being different processes. I recommend the authors take another approach while framing the story.

2\) Data showing that FUDR prevents rRNA reactivation (Figure 5), but not nucleolar expansion (Figure 4), post ARD seem, at least superficially, to be contradictory. The authors should include a description in their discussion of this issue and why they feel the results are not problematic for their model.

3\) I did not think the rRNA/total and 28S/18S data in Figure 5 added much to the story. Also, rRNA processing defects (5J, arrow) were quite subtle and not definitive. I suggest the data be removed.

4\) After reading the paper, I wanted to know what effect FUDR might have on RNA populations in non-ARD worms. If RNA metabolism is similarly affected, how do adult worms survive on FUDR plates? If RNA metabolism is recalcitrant to FUDR in non-ARD animals, why and how? The subject might be worth mentioning in discussion.

5\) Results paragraph two. The logic of this introduction paragraph was difficult to follow. A rewrite is needed.

6\) If memory serves, *glp-1*(ts) animals do not actually lack all germ cells (they still have a small pool (\~8) of mitotically dividing germ cells). If I\'m right, authors should modify text accordingly.

7\) Essential information is missing from figure legends. Genotypes need to be listed (i.e. Figure 2C) and the number of independent replicates (vs. technical replicates) of experiments should be listed. Additional details would be helpful- such as were the samples in 5J diluted similarly to samples in 5A?

Reviewer \#2:

The Burnaevskiy et al. manuscript reports that worms exposed to FUDR, which is generally thought to inhibit DNA replication, is not able to rejuvenate after ARD (adult reproductive diapause). The mechanisms allowing worms to rejuvenate after a prolonged period in ARD are largely unknown, so the finding that FUDR blocks rejuvenation is new and interesting. The authors also demonstrated that germlineless mutants can rejuvenate from ARD (in somatic tissues), indicating rejuvenation does not depend on a germline signal, and is likely cell autonomous. The data and conclusions on the effect of FUDR and germline are supported by solid data. The authors then performed a series of experiments in an attempt to identify the mechanism whereby FUDR blocks rejuvenation. This later part is more problematic, which are detailed below.

1\) The *plog-1* mutant data are intriguing, but the fact that the homozygous mutants develop into morphologically normal, but sterile adults indicates that the mutant worms must have inherited sufficient amount of PLOG-1 to sustain somatic development. This indicated that maternal PLOG-1 is sufficient to support somatic DNA replication. Because of this, the fact that the *plog-1* mutant can rejuvenate its somatic tissues after ARD cannot be interpreted to indicate rejuvenation can take place in the absence of mitochondrial DNA replication. It is possible that maternal PLOG-1 is sufficient to support mito DNA replication in somatic tissues during post-ARD rejuvenation.

The authors should recover dissected somatic tissues (after removal of dissected gonads) and quantify mitochondrial DNA (using qPCR) in ARD and post-ARD animals to assess whether mitochondrial DNA replication can take place.

2\) The uracil and thymidine supplement experiments need additional controls.i) Uracil can in fact be converted into deoxyuracil, which can be incorporated into DNA. The authors should do a parallel supplement experiment using deoxyuracil. If they get no rescue with deoxyuracil, but only with uracil, then that would provide much stronger evidence of an effect on RNA metabolism, and not DNA.ii) The *tyms-1* mutant experiment appears to suggest thymidine is in excess, as the worms likely get them through their bacteria diet. In this is true, then the thymidine supplement experiment is not as meaningful, as thymidine is likely already in excess. The authors can use a bacterial strain lacking thymidine to further test this point.

3\) Although the authors observed interesting changes in nucleolar size in worms treated with FUDR, ultimately the size of the nucleolar did not appear to correlate with rejuvenation / rRNA biogenesis.

First, FUDR did NOT block nucleolar expansion in post-ARD worms, even though these worms failed to rejuvenate. Also, FUDR induced greater nucleolar expansion in control wild-type worms, even though these worms did not need to rejuvenate.

Moreover, total RNA remained very low in post-ARD worms treated with FUDR. Total RNA levels were not significantly different in control worms treated with FUDR. Therefore, total RNA levels did NOT correlate with nucleolar expansion.

It is unclear why the authors spent three paragraphs in the Discussion stating the importance of nucleolar size / expansion, while there is little evidence that this change is important for the recovery of RNA levels / rejuvenation post-ARD. The Discussion needs to be rewritten to discuss the contradicting results on nucleolar size.

4\) Figure 5 indicates that total RNA levels plummeted during ARD, and their levels recovered during rejuvenation. These results indicated that ALL or some RNAs could be important for rejuvenation. The authors hypothesized that rRNA biogenesis to be key, however the evidence to support this is weak, largely based on a skewed ratio of rRNAs recovery relative to total RNA (and an UNcorrelated nucleolar expansion). The authors need to use a genetic way to specifically interfere with rRNA processing / biogenesis, and test whether that is sufficient to block rejuvenation. This will be a key and necessary experiment to support the authors\' conclusion that rRNA processing / biogenesis is important.

Reviewer \#3:

*C. elegans* adult reproductive diapause (ARD) is a state of reproductive quiescence that forms in response to late larval food deprivation. Upon ARD entry, animals remodel much of their germline and other tissues, and live months without food. Upon ARD recovery, they rejuvenate germline and soma, and reproduce. This is therefore an important model for long-lived states of quiescence and rejuvenation. However, the genetic and physiologic requirements for entry, maintenance and exit are relatively unknown.

This study by Kaeberlein and colleagues explores some of the requirements for ARD recovery. They show that the nucleotide analog FUDR inhibits recovery, while having little effect on late larval development under ad libitum conditions. Similarly a temperature sensitive mutation in the thymidylate synthase, *tyms-1*, inhibits recovery. Interestingly, uracil supplementation restores recovery in the presence of FUDR, while thymine does not, implicating RNA rather than DNA metabolism.

Indeed they find that overall levels of RNA are down in ARD and stay low with FUDR treatment. The authors associate recovery to effects on rRNA production, since animals in ARD have small nucleoli and low levels of rRNA, while animals undergoing recovery enlarge their nucleoli and produce higher levels of rRNA. FUDR exposure in ARD inhibits rRNA production and may cause nucleolar stress.

This study addresses an important question on a poorly understood state of organismal quiescence and rejuvenation. The work implicates RNA rather than DNA metabolism as the major process important for recovery. The implication of RNA metabolism in the recovery process is intriguing, but perhaps not surprising, since global processes such as rRNA and protein synthesis would seem to be essential to initiate (post-mitotic) regrowth. One might find that cycloheximide treatment would similarly affect recovery. Yet the connection to rRNA production and rejuvenation is correlative and not proven, since FUDR could be arresting growth through other means, (e.g. nucleolar stress induced arrest through p53?) with secondary consequences on recovery. The authors also test the potential contribution of POLgamma, and germline proliferation to recovery but do not really explore other genetic requirements. While the direction of the authors work is intriguing, the study seems somewhat limited in scope and correlative.

Other points:

1\) Can the authors rule out that ARD worms might be more sensitive to drugs or toxins in general?

2\) Recovered ARD worms on FUDR pump little (similar to ARD worms, Figure 2). Perhaps they do not eat enough to start recovery. Can this be ruled out?

3\) The authors should measure DNA amounts in the *glp-1* ARD worms and upon recovery to have a clear measure of DNA metabolism.

4\) Quality of the pictures must be improved (e.g. orientation, spacing of the worms, illumination of the pictures, no air bubbles). Scale bars missing, graphs are of different sizes. Genes should be in italic.

5\) Figures showing nucleoli should also show DAPI staining of the nucleus.

Nucleolar to nuclear ratios might be informative, since intestinal nuclei also undergo endoreplication.

6\) It looks like FUDR treatment causes rRNA degradation. Might FUDR activate a degradative processes rather than inhibit synthesis?

Comments from the consultation:

Reviewer 1:

The deoxyuracil control experiment suggested by reviewer \#2 seems like a reasonable request. I also agree with \#2 that \"rRNA explains ARD recovery\" hypothesis is weak. Authors could do more experiments to test the idea as suggested, or just drop the claim. I am ok with either. Finally, discussing the disconnect between role of FUDR on nucleolar size and ARD recovery is definitely needed. I agree with \#3 that the \"RNA-metabolism required for ARD recovery\" hypothesis is correlative and not actually all that surprising. I liked the paper, however, and with some editing think it will make a fairly interesting read.

Reviewer 2:

Out of the three lines of experiments I suggested, I also think the deoxyuracil is the most straight forward and can really help to strengthen their argument that RNA metabolism is key.

I\'m not completely convinced by their argument that DNA replication is not involved -- so I suggested a follow-up there. I think Reviewer 3 also suggested some follow up on testing DNA replication further?

I am OK with them not doing more experiments to better support the rRNA and nucleolar expansion model, if they would substantially dial down on their speculation in the Discussion.

Reviewer 3:

I would support this paper with revisions.

1\) The disconnect between FUDr and nucleolar size could be handled in discussion.

2\) The deoxyuracil feeding experiment would be good.

3\) If they want to solidify the connection to rRNA they could knockdown the Pol1 subunit rrn-3, and see if this impacts recovery. Or they could deal with the issue as a point of discussion.

I would add that the figures need major improvement.

10.7554/eLife.36194.035

Author response

> Below are the reviews presented first, followed by the reviewer discussion, where the reviewers had other suggestions. As you can see, there is ample support for publishing this paper but some simple suggested experiments. The reviewers were mindful to not request inordinately laborious experiments or experiments that would constitute the next paper in this analysis; their suggestions were reasonable.
>
> Reviewer \#1:
>
> \[...\] 1) Attempts to link the ideas of tissue rejuvenation after ARD and tissue rejuvenation after aging felt shoehorned to me. I would guess that recovery from acute starvation and recovery from the damage of long-term aging are going to end up being different processes. I recommend the authors take another approach while framing the story.

We appreciate the reviewer's perspective on this and we have toned down discussion of potential similarities between normal and "diapaused" aging and we made textual changes to highlight that we are interested in both preservation of tissue functionality by diapause and its restoration after diapause exit. We have also largely replaced the word "rejuvenation" with words like "restoration of function", "improvement", and "recovery" to describe diapause exit. We agree that the mechanisms of aging/damage that occur during normative aging could very well be different than those that occur during ARD. Having said that, we and others have seen evidence for at least superficially similar types of damage during ARD and other diapause states in worms, including structural degeneration in muscle, loss of proteostasis, and mitochondrial dysfunction. Thus, we believe it is an open question.

> 2\) Data showing that FUDR prevents rRNA reactivation (Figure 5), but not nucleolar expansion (Figure 4), post ARD seem, at least superficially, to be contradictory. The authors should include a description in their discussion of this issue and why they feel the results are not problematic for their model.

Thank you for noting this potentially confusing aspect of the data. We believe that our observations indicate that nucleolar expansion occurs when the cell attempts to induce ribosome biogenesis, which is blocked by FUDR. We have attempted to clarify our interpretation in the Discussion with the following text:

"In this regard, it is interesting that FUDR blocked the increase in rRNA upon exit from ARD but did not fully prevent expansion of the nucleolus, indicating that nucleolar size alone does not always reflect rRNA and ribosome biogenesis. \[...\] Alternatively, the increase of nucleolar size in post-diapause animals may reflect a compensatory response to impaired rRNA production caused by the drug, as we have observed that *ad libitum* fed control animals have larger nucleoli following treatment with FUDR."

> 3\) I did not think the rRNA/total and 28S/18S data in Figure 5 added much to the story. Also, rRNA processing defects (5J, arrow) were quite subtle and not definitive. I suggest the data be removed.

We can appreciate this viewpoint and we have attempted to tone down the emphasis on rRNA, although we feel this is the most likely explanation for the effects of FUDR in the context of restoration of function following ARD as well as the various phenotypes associated with FUDR treatment in otherwise normally maintained animals. In response to these concerns, we have moved panel 5J into supplemental images (Figure 5---figure supplement 1) and restrained ourselves from drawing strong conclusions from this result. We feel it is important to make this piece of data available to the scientific community, since it may provide useful information for other labs, considering the widespread use of this drug among *C. elegans* researchers.

We have additionally attempted to reshape the RNA part of the story according to common suggestions of the reviewers to tone down rRNA hypothesis. We present analysis of changes of RNA profile in post-ARD and control conditions and highlight the changes of rRNA content, but we do not insist on rRNA changes as the key mechanism.

> 4\) After reading the paper, I wanted to know what effect FUDR might have on RNA populations in non-ARD worms. If RNA metabolism is similarly affected, how do adult worms survive on FUDR plates? If RNA metabolism is recalcitrant to FUDR in non-ARD animals, why and how? The subject might be worth mentioning in discussion.

We have added a brief discussion of this. The data in Figure 5 demonstrate that RNA metabolism is not affected as strongly in somatic tissues of non-ARD adult animals (these experiments were done in *glp-1* animals to avoid effects on the germline), which likely reflects the fact that adult *C. elegans* are not undergoing rapid growth and therefore likely do not need to produce as many new ribosomes or RNA. We do detect a trend toward decreasing total RNA content and rRNA/total RNA ratio in adult animals and 28S/18S was modestly but significantly affected in control (non-ARD) animals.

> 5\) Results paragraph two. The logic of this introduction paragraph was difficult to follow. A rewrite is needed.

This paragraph has been revised for clarity.

> 6\) If memory serves, glp-1(ts) animals do not actually lack all germ cells (they still have a small pool (\~8) of mitotically dividing germ cells). If I\'m right, authors should modify text accordingly.

Thank you for correcting this. We have revised the text to indicate that a small number of GSCs may still be present in the *glp-1(e2141)* mutants. Literature suggests between 0-12 GSCs persist.

> 7\) Essential information is missing from figure legends. Genotypes need to be listed (i.e. Figure 2C) and the number of independent replicates (vs. technical replicates) of experiments should be listed. Additional details would be helpful- such as were the samples in 5J diluted similarly to samples in 5A?

We have added the missing information. We indicate the number of independent replicates in the Materials and methods and in the numerical data section.

> Reviewer \#2:
>
> \[...\] 1) The plog-1 mutant data are intriguing, but the fact that the homozygous mutants develop into morphologically normal, but sterile adults indicates that the mutant worms must have inherited sufficient amount of PLOG-1 to sustain somatic development. This indicated that maternal PLOG-1 is sufficient to support somatic DNA replication. Because of this, the fact that the plog-1 mutant can rejuvenate its somatic tissues after ARD cannot be interpreted to indicate rejuvenation can take place in the absence of mitochondrial DNA replication. It is possible that maternal PLOG-1 is sufficient to support mito DNA replication in somatic tissues during post-ARD rejuvenation.
>
> The authors should recover dissected somatic tissues (after removal of dissected gonads) and quantify mitochondrial DNA (using qPCR) in ARD and post-ARD animals to assess whether mitochondrial DNA replication can take place.

We thank the reviewer for this comment and apologize for not more clearly stating that prior work with this mutant indicated no active replication of mtDNA during development or adulthood suggesting that there already exist sufficient copies of the mtDNA following embryogenesis to support development (Bratic *et al.*). To further confirm this is the case, we performed single worm qPCR measurement of mitochondrial DNA content using the *glp-1* mutant strain. We did not detect mtDNA increase in post-diapause animals. The data are now available in the Figure 3---figure supplement 1B.

> 2\) The uracil and thymidine supplement experiments need additional controls.i) Uracil can in fact be converted into deoxyuracil, which can be incorporated into DNA. The authors should do a parallel supplement experiment using deoxyuracil. If they get no rescue with deoxyuracil, but only with uracil, then that would provide much stronger evidence of an effect on RNA metabolism, and not DNA.

We believe that the reviewer meant deoxyuridine. We considered this experiment, but felt that it was not informative because deoxyuridine would likely compete with FUDR (which is 5-fluoro-deoxyuridine) for the same enzymatic target(s). Further deoxyuridine can be converted to uridine through the same mechanism as FUDR is converted to 5-fluorouridine, potentially diluting out any toxicity from 5-fluorouridine. Thus, we reasoned that deoxyuridine will rescue the effects of FUDR regardless of whether FUDR is impairing DNA synthesis, RNA synthesis, or both. Nonetheless, we have added this experiment in the revision as requested.

We have also added what we hope will be more convincing additional studies using uridine and thymidine. While the deoxyuridine results are difficult to interpret as described above, we observed that uridine rescued phenotypes associated with FUDR while thymidine did not, arguing that RNA and not DNA metabolism are essential during post-ARD recovery. The data are now available in the Figure 3---figure supplement 1C,D.

To further test this model, we also performed additional experiments using bacterial strains deficient in nucleotide metabolism as described in the next response.

> ii\) The tyms-1 mutant experiment appears to suggest thymidine is in excess, as the worms likely get them through their bacteria diet. In this is true, then the thymidine supplement experiment is not as meaningful, as thymidine is likely already in excess. The authors can use a bacterial strain lacking thymidine to further test this point.

Thank you for suggesting the use of bacterial strains deficient in nucleotide metabolism. We chose not to utilize thymidine-deficient bacterial cells because these cells do not grow without thymine and succumb to "thymidineless death". We reasoned that reduced growth and viability of the bacterial food source could prevent interpretation of this experiment.

We have therefore performed an alternative experiment that would be easier to interpret. It has been shown recently that bacterial metabolism affects response of *C. elegans* to drugs, including FUDR. We therefore used bacterial strains deficient in nucleotide-processing enzymes, namely upp (uracil phosphoribosyltransferase) (strain JW2483-1), tdk (thymidine kinase) (strain JW1226-1), and parent strain of the Keio collection BW25113. Cells were grown in LB and seeded on NGM plates containing FUDR. We predicted that upp-deficient strain should alleviate toxicity of FUDR, due to inability to metabolize the drug into RNA precursor. In contrast, we expected that tkd-deficient cells, which are unable to process FUDR into thymidine analog, should not reduce toxicity of FUDR compared to the parent strain. As shown in the new Figure 3C, this is exactly what we have found. These results further argue that RNA, and not DNA metabolism is essential for post-ARD recovery. The data are now available in the Figures 3C,F.

> 3\) Although the authors observed interesting changes in nucleolar size in worms treated with FUDR, ultimately the size of the nucleolar did not appear to correlate with rejuvenation / rRNA biogenesis.
>
> First, FUDR did NOT block nucleolar expansion in post-ARD worms, even though these worms failed to rejuvenate. Also, FUDR induced greater nucleolar expansion in control wild-type worms, even though these worms did not need to rejuvenate.
>
> Moreover, total RNA remained very low in post-ARD worms treated with FUDR. Total RNA levels were not significantly different in control worms treated with FUDR. Therefore, total RNA levels did NOT correlate with nucleolar expansion.
>
> It is unclear why the authors spent three paragraphs in the Discussion stating the importance of nucleolar size / expansion, while there is little evidence that this change is important for the recovery of RNA levels / rejuvenation post-ARD. The Discussion needs to be rewritten to discuss the contradicting results on nucleolar size.

We apologize for not more clearly describing these results and why we think they are important. We have modified the Discussion to clarify our interpretation. We do feel that the dramatic effect of ARD on nucleolar size is relevant and informative, especially in the context of other literature linking nucleolar size to longevity, but size alone is not a clear indicator of rRNA and ribosome biogenesis, as our results with FUDR clearly indicate. The Discussion of this has been modified as follows:

"In this regard, it is interesting that FUDR blocked the increase in rRNA upon exit from ARD but did not fully prevent expansion of the nucleolus, indicating that nucleolar size alone does not always reflect rRNA and ribosome biogenesis. Nucleolus is a dynamic organelle that houses various enzymes for RNA processing and its composition is responsive to cellular stresses. Therefore, one potential explanation for these results is that nucleolar size may be driven by early recruitment of rRNA-processing enzymes such as FIB-1 along with other machinery needed for ribosome biogenesis, and this step is not blocked by the drug. Alternatively, the increase of nucleolar size in post-diapause animals may reflect a compensatory response to impaired rRNA production caused by the drug, as we have observed that *ad libitum* fed control animals have larger nucleoli following treatment with FUDR."

> 4\) Figure 5 indicates that total RNA levels plummeted during ARD, and their levels recovered during rejuvenation. These results indicated that ALL or some RNAs could be important for rejuvenation. The authors hypothesized that rRNA biogenesis to be key, however the evidence to support this is weak, largely based on a skewed ratio of rRNAs recovery relative to total RNA (and an UNcorrelated nucleolar expansion). The authors need to use a genetic way to specifically interfere with rRNA processing / biogenesis, and test whether that is sufficient to block rejuvenation. This will be a key and necessary experiment to support the authors\' conclusion that rRNA processing / biogenesis is important.

We thank the reviewer for this comment, and we agree that we cannot definitively differentiated between the importance of total RNA, specific mRNAs, and ribosomal rRNA in this context. We respectfully disagree, however, that knocking down rRNA processing or biogenesis would be informative in this context. Genetically blocking rRNA processing and biogenesis would have a similar effect on total RNA to what we observed, due to the fact that functional ribosomes are required for production of transcriptional machinery during periods of robust growth. In addition, there is no experimentally clean way to perform such a study, due to the fact that RNAi feeding (to knock down rRNA processing in this case) upon release from ARD does not work efficiently (our unpublished data). We have now explicitly stated that we cannot rule out alternative models in the discussion and we hope this will satisfy this concern.

> Reviewer \#3:
>
> \[...\] Other points:
>
> 1\) Can the authors rule out that ARD worms might be more sensitive to drugs or toxins in general?

We have attempted to address this concern by treating ARD animals with hydroxyurea, which has several effects including inhibition of ribonucleotide reductase (DNA synthesis), catalase, and carbonic anhydrase. When ad libitum fed early-mid L4 animals are transferred on NGM media containing hydroxyurea, they experience rapid demise and collapse of body morphology. In contrast post-ARD animals manage to show some growth and visual improvements. Thus, for HU, post-ARD animals are more resistant to the drug. Therefore, it is unlikely that ARD animals are more sensitive to toxins in general. We have now added this result as Figure 1---figure supplement 1.

> 2\) Recovered ARD worms on FUDR pump little (similar to ARD worms, Figure 2). Perhaps they do not eat enough to start recovery. Can this be ruled out?

This is a reasonable suggestion that we have now added to the discussion. Indeed, inability of the post-ARD animals to increase their pumping rate in the presence of FUDR may stall the rest of the recovery. Alternatively, inability of these animals to reinflate their intestine in the presence of FUDR may be another roadblock for the recovery. We cannot yet dissect the mechanistic role of different somatic tissues during recovery. Regardless of which tissue(s) become limiting for recovery, this does not impact our model that cell intrinsic effects on RNA metabolism underlie the deficits in restoration of function.

> 3\) The authors should measure DNA amounts in the glp-1 ARD worms and upon recovery to have a clear measure of DNA metabolism.

Following suggestion from another reviewer we have performed qPCR on *glp-1* animals to measure mitochondrial DNA content. We do not detect increase of mtDNA content in post-diapause animals. See Figure 3---figure supplement 1B.

We have also added additional analysis of the nuclear DNA. We decided not to use qPCR to measure nuclear DNA content, because this assay likely would not be sensitive enough: ARD animals are anatomically mature and qPCR most likely would not detect a small burst of nuclear DNA synthesis, if let's say few cells undergo final round of division and endoreduplication. We therefore applied alternative approaches to analyze the role of nuclear DNA metabolism during recovery.

First, we imaged newly synthesized DNA in post-ARD and control animals using nucleotide analog EdU with subsequent click-chemistry detection of the probe. We have observed birth of germline and somatic nuclei when control animals are grown in the presence of EdU from egg. In contrast, we can only detect EdU incorporation in the germline of post-ARD animals. These results indicate that no detectable somatic cell division occurs in post-ARD animals. We present the data in Figure 2D.

We also attempted to address the potential for DNA synthesis in endoreduplicating intestinal cells. EdU did not label endureduplication in the intestine even in control animals grown on EdU-labeled cells from egg. We therefore decided to better analyze intestine, since this tissue undergoes dramatic morphological improvement during recovery and intestinal cells usually undergo a final round of endoreduplication during adult molt. We estimated ploidy of intestinal cells in diapaused animals using DAPI staining. We have found that intestinal nuclei contain approximately 16 equivalents of diploid genomes, indicating that these cells finished endoreduplications. We show the data in the Figure 2E.

Third, we analyzed recovery of *cye-1* (cyclin E) mutant animals. These animals are maintained as a heterozygous strain with a balancer chromosome. Homozygous mutants are viable, but do not complete endoreduplications, have smaller body size and have clear defects in the development of the reproductive system. We analyzed recovery of these animals from the diapause and their sensitivity to FUDR. We found that animals do recover from the diapause normally (judged by pumping rate and overall body morphology) and are sensitive to FUDR. Therefore, reactivation of cell cycle (or endoreduplication) is not necessary for post-diapause recovery. The data are presented in the Figures 2F,G, H.

> 4\) Quality of the pictures must be improved (e.g. orientation, spacing of the worms, illumination of the pictures, no air bubbles). Scale bars missing, graphs are of different sizes. Genes should be in italic.

We replaced low contrast images with better ones and added scale bars. We also changed the size of the graphs and italicized the genes.

> 5\) Figures showing nucleoli should also show DAPI staining of the nucleus.
>
> Nucleolar to nuclear ratios might be informative, since intestinal nuclei also undergo endoreplication.

We have now added images of nucleoli with DAPI in ARD and post-ARD animals. We have also provided quantification of the nucleoli/nucleus ratio in these condition. See Figure 4---figure supplement 1. Also see Figure 3---figure supplement 1 for estimation of ploidy in ARD animals. As described above, our estimation of intestinal ploidy in ARD animals indicate that they did complete all the rounds of endoreduplication.

> 6\) It looks like FUDR treatment causes rRNA degradation. Might FUDR activate a degradative processes rather than inhibit synthesis?

This is difficult to answer definitively based on our data or other limited data in the literature. The one piece of data arguing against significant degradation is that adult ad libetumfed animals show relatively modest changes in total RNA or rRNA in response to FUDR. We believe this reflects the much lower demand for new RNA synthesis in fully developed somatic tissues as opposed to rapidly growing somatic tissues undergoing remodeling and repair, such as upon release from ARD. It is however not unreasonable to suggest that if FUDR causes severe RNA stress then it can cause some RNA degradation as well. We have added this notion into the Discussion section.

> Comments from the consultation:
>
> Reviewer 1:
>
> The deoxyuracil control experiment suggested by reviewer \#2 seems like a reasonable request. I also agree with \#2 that \"rRNA explains ARD recovery\" hypothesis is weak. Authors could do more experiments to test the idea as suggested, or just drop the claim. I am ok with either. Finally, discussing the disconnect between role of FUDR on nucleolar size and ARD recovery is definitely needed. I agree with \#3 that the \"RNA-metabolism required for ARD recovery\" hypothesis is correlative and not actually all that surprising. I liked the paper, however, and with some editing think it will make a fairly interesting read.

1\) We performed the requested deoxyuridine experiment as well as several additional experiments to address this point. Please see description of this and some other experiments above.

2\) We toned down rRNA hypothesis and reshaped RNA part of the story.

3\) We discuss potential reasons for disconnect between nucleolar size and post-ARD recovery.

> Reviewer 2:
>
> Out of the three lines of experiments I suggested (Rev 2), I also think the deoxyuracil is the most straight forward and can really help to strengthen their argument that RNA metabolism is key.
>
> I\'m not completely convinced by their argument that DNA replication is not involved -- so I suggested a follow-up there. I think Reviewer 3 also suggested some follow up on testing DNA replication further?
>
> I am OK with them not doing more experiments to better support the rRNA and nucleolar expansion model, if they would substantially dial down on their speculation in the Discussion.

1\) We did perform deoxyuridine experiment. Please see description of this and some other experiments above.

2\) We have performed additional experiments to analyze DNA vs RNA requirements during recovery. Please see above.

3\) We toned down rRNA hypothesis.

> Reviewer 3:
>
> I would support this paper with revisions.
>
> 1\) The disconnect between FUDr and nucleolar size could be handled in discussion.
>
> 2\) The deoxyuracil feeding experiment would be good.
>
> 3\) If they want to solidify the connection to rRNA they could knockdown the Pol1 subunit rrn-3, and see if this impacts recovery. Or they could deal with the issue as a point of discussion.
>
> I would add that the figures need major improvement.

1\) We toned down rRNA hypothesis and directly address the disconnect between nucleolar size and effects of FUDR.

2\) We did perform deoxyuridine experiment. Please see description of this and some other experiments above.

3\) Genetic inactivation of specific enzymes such as rrn-3 during recovery would be a great way to study post-diapause recovery. This approach would require inactivation of the candidate genes specifically during recovery, which in theory can be achieved through RNAi feeding. Unfortunately, our experience is that RNAi does not work efficiently in post-ARD animals. This is most likely due to the timing of RNAi effect, which may not be induced rapidly enough to prevent substantial signs of improvement in post-ARD animals during the first 48 hours of recovery.

4\) We updated some of the microscopy images and we ensured similar sizes of bar graphs in different figures for a better aesthetic look.
